AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Evolution of AML Treatment for Less Fit Patients
This chapter examines the treatment evolution for patients with acute myeloid leukemia who are not candidates for intensive therapy. It covers a case study on IDH1 mutated AML and reviews the shift from traditional chemotherapy to modern lower-dose therapies, highlighting significant studies that have influenced current practices.